Fesoterodin Spirig HC retard 4 mg

Fesoterodin Spirig HC retard 4 mg is a medicine authorised by Swissmedic under authorisation number 69550. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 September 2024 and the authorisation is limited until 04 September 2029. ATC code G04BD11 places the medicine in the group Urologicals.

  • Dispensing category B
  • Authorisation number 69550
  • ATC G04BD11
  • Synthetic medicines
Authorisation data
Authorisation number69550
NameFesoterodin Spirig HC retard 4 mg
Full nameFesoterodin Spirig HC retard 4 mg, Retardtabletten
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeG04BD11
First authorisation05 September 2024
Authorisation validity04 September 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Fesoterodin Spirig HC retard 4 mg, RetardtablettenB05 September 2024
2Fesoterodin Spirig HC retard 8 mg, RetardtablettenB05 September 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
114Tablette(n)G04BD1105.02.0.B
284Tablette(n)G04BD1105.02.0.B
314Tablette(n)G04BD1105.02.0.B
484Tablette(n)G04BD1105.02.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Fesoterodin Spirig HC retard 4 mg authorised in Switzerland?

Yes. Fesoterodin Spirig HC retard 4 mg is authorised by Swissmedic under authorisation number 69550, data as of 01 September 2026. The authorisation is limited until 04 September 2029.

Which dispensing category does Fesoterodin Spirig HC retard 4 mg have?

Fesoterodin Spirig HC retard 4 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fesoterodin Spirig HC retard 4 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com